No that's US. It is a premium as its trading at circa 90, so taking into account the dilution of an extra 20% shares( if they take that option) then it is a premium.
I am more than happy to be proven wrong. If Amgen took 20% at 1.20 plus funding through to production, then I could see UNIS at $2+ dollars on deal being signed.
77
- Forums
- ASX - By Stock
- UNS
- Ann: 8-K Amgen and Orbimed Amendment Agreements
Ann: 8-K Amgen and Orbimed Amendment Agreements, page-138
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online